Spots Global Cancer Trial Database for esophagogastric junction
Every month we try and update this database with for esophagogastric junction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) | NCT04752358 | Esophageal Canc... Esophagogastric... | Autologous gene... | 18 Years - 75 Years | Adaptimmune | |
| Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer | NCT04592913 | Gastrointestina... Esophagogastric... | Durvalumab FLOT chemothera... | 18 Years - 200 Years | AstraZeneca | |
| Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database | NCT05419349 | Adenocarcinoma ... | esophagogastric... | - | Fujian Medical University Union Hospital | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer | NCT04443478 | Gastric Cancer | Radical gastrec... | 18 Years - 80 Years | Peking University | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas | NCT01504256 | Gastric Adenoca... Siewert Type II... Siewert Type II... | catumaxomab, Fl... Fluorouracil, l... | 18 Years - | AIO-Studien-gGmbH | |
| Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction | NCT00442507 | Esophageal Neop... Esophageal Dise... | Erlotinib Avastin | 18 Years - | Washington University School of Medicine | |
| Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer | NCT04592913 | Gastrointestina... Esophagogastric... | Durvalumab FLOT chemothera... | 18 Years - 200 Years | AstraZeneca | |
| An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers | NCT03662659 | Gastric Cancer Cancer of the S... Esophagogastric... | BMS-986213 Nivolumab XELOX FOLFOX SOX | 18 Years - | Bristol-Myers Squibb | |
| Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases | NCT06374888 | Her2-positive A... | Neratinib malea... | 18 Years - | Convalife (Shanghai) Co., Ltd. | |
| Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database | NCT05419349 | Adenocarcinoma ... | esophagogastric... | - | Fujian Medical University Union Hospital | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction | NCT02741778 | Adenocarcinoma | Minimally invas... Open group | 20 Years - 70 Years | Anhui Provincial Hospital | |
| Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology | NCT03092518 | Gastric Adenoca... Esophagogastric... Gastric Cancer | Surgery Cisplatin Mitomycin C Sodium Thiosulf... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) | NCT04752358 | Esophageal Canc... Esophagogastric... | Autologous gene... | 18 Years - 75 Years | Adaptimmune |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
